chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First two days after receiving vaccine arm was sore which was expected. Went away after the first two days and was fine. Then Thursday 04/08, my arm was noticeably sore. Saturday my arm was red, swollen, burning, and sore at the injection site. Today, Sunday, the symptoms continue.
Patient experienced approximately 15-20 spasm episode over the course of 12 hours after immunizations. Episodes of facial grimace and body "tightening" for 1-2 seconds. No post-lethal phase. Tm-100.2" Episodes did not recur thereafter.
Myalgia, Fever, UrticariaPruritus, Diarrhea, NauseaVomiting, Sore Arm, fatigue Narrative:
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Mar2021 as dose 1, single (Lot number: EN6198), in left arm, on 25Mar2021 as dose 2, single (Lot number: ER8732), in left arm and on 03Oct2021 as dose 3 (booster), single (Lot number: 301358A) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Epilepsy" (unspecified if ongoing); "Celiac disease" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing); "Overweight" (unspecified if ongoing). Concomitant medication(s) included: DEPAKOTE ER; METFORMIN; WELCHOL; METOPROLOL; LOSARTAN/HCTZ; VITAMIN D3; IRON; FOLIC ACID; VITAMIN B12 [VITAMIN B12 NOS]. Past drug history included: Gluten, reaction(s): "known allergies Gluten". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Indication: Covid-19 treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19.  clinical Course:Women's daily multivitamin.  No follow-up attempts are possible. No further information is expected.
Pain, edema, redness, pruritis, welts and warmth to (L) upper arm injection site area.
chills the evening of injection. took a single ibuprofen, which was sufficient to alleviate the symptom
INJECTION SITE DISCOMFORT, GASSINESS, STOMACH PAIN, BURPING, CHILLS, SLIGHT FEVER, HEADACHE, SWELLING ON LEFT MIDDLE FINGER
2nd moderna covid19 vaccination received on 05/24.  Swelling began a day later and continue, PT reporting swelling of upper arm.  From injection area to elbow.  No rash other then little dots, swelling is becoming unease.  Isolated to upper left arm.  Recommended pt to follow up with PCP or their oncologist.
I GAVE PATIENT AN EMPTY SYRINGE THEN REALIZED.  APOLOGIZED & TOLD HER WHAT HAPPENED & GAVE INTENDED VACCINE.
Information has been received from a Licensed Practical Nurse referring to unspecified numbers of patients of unknown age and gender. The patients' medical history, concomitant therapy and drug reactions were not reported. On unspecified dates, the patients were vaccinated with improperly stored M-M-R II (dose and route unspecified) (lot # K011188, expiry date 12-AUG-2016, lot # L012481, expiry date 10-APR-2017, unspecified doses). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Received pneumovax inj on 05/29/02. Noted chills, body aches, left arm red/swollen and warm 05/29/02 PM. Also reported porblem sleeping (more wakefulness). Pt reported symptoms to office nurse 05/31/02 AM. No treatments ordered by MD. Chart noted for local reaction to pneumovax.
Patient had swelling at site of injection (right arm ), also swelling at left arm ( not as bad as on right arm ), swelling on right leg and left leg (less compare to right leg ), no shortness of breath or hives.
This case was reported by a nurse and described the occurrence of seizure in a 36 year old male patient who received hepatitis B vaccine recombinant.  On 04/19/2004, the patient received the first dose of Engerix-B.  Approximately 10 minutes following the administration of Engerix-B, on 04/19/2004 the patient experienced a seizure.  The patient was seen in an emergency room.  The event resolved on 04/19/2004.  The vaccination series with Engerix-B was discontinued.  Comment:  Seizure was assessed as medically serious by GSK.
Grandma called to report patient "fainted" at home around 1230 pm. Hit her head on lampshade and floor. Got on couch to recover. Stated she felt dizzy and ringing in her ears prior to passing out. Had not eaten all day except some water. Patient alert and oriented. Encouraged to drink SPRITE and have snack and rest. Grandma to call physician about hitting her head. Advised to go to ER or call primary physician if symptoms not resolved. Advised Grandma that this is a side effect from vaccines. Grandma understanding.
9/26/21 pt presents to ED after testing positive for COVID on 9/21/21 at the local health department; she has had cold sx, fever, some diarrhea x approximately 1 wk; the last 2 days she's had more fatigue and SOB with exertion; has had a pulse ox of 80% on RA at home; admitted to hosp; COVID PNA with hypoxia; O2 supplementation; transferred to ICU; given dexamethasone, Vitamins C and D, zinc; pt went into A Fib RVR and her respiratory status worsened; she had to be intubated; was made a DNR by husband and eventually transitioned to comfort measures; she passed away in the hospital
Rash (papules & vesicles) noted on dorsum (left greater than right) of both feet 3 days post SmPx vax (primary). Tx'd symptomatically (no meds) rash diminished over 72 hrs.
Pericarditis 3 days in hospital Taking Colchicine 0.6 mg twice daily Had Ecocardigran C Reactive Protein was 233, far above normal. Still have an issue. lots of inflammation.
Nausea, vomiting, chest pain and dyspnea Narrative:  A 59yo male with a historical ADR of chest pain, dyspnea, nausea and vomiting, after receiving Pfizer's Covid-19 vaccine. The reporting physician, note included the patient was hospitalized at Hospital. The non-agency record summary from Medical Center showed, patient was admitted for chest pain observation and had -ve Troponins, CXR, EKG - NSR at 65 with T wave inversion in I, II, III AVF and V4 - V6" and was cleared for outpatient f/u February 10, 2021 advice line patient reported note stated the reaction started 2 days after receiving Covid vaccine on January 30, 2021 February 24th PCC nurse's f/u note included patient had minimal side effect with the 2nd shot which was administered on February 20, 2021 PMH - Gout, HTN, Chest Pain, Prostate Cancer, Cerebral Infraction, Apraxia due to cerebrovascular accident, Aphasia, Hemorrhagic Stroke
Right arm (deltoid) with cellulitis and no fever. Prescribed Keflex x 1 week.
Information has been received from a licensed practical nurse concerning a 30 year old black female who on 04-SEP-2007 was vaccinated with her first dose of pneumococcal 23v polysaccharide vaccine (Lot #657039/0698U) intramuscularly in the left arm. On 05-SEP-2007, the patient developed a severely swollen and painful left arm, and itching. On 07-SEP-2007, the patient was seen by the physician and there was a 3" X 4" red swollen area at the injection site which extended down her arm and into axilla. The patient was given 40 mg. of KENALOG intramuscularly and MEDROL DOSE PAK. The reaction was resolved within these measures. No additional information is expected.
feeling of throat closure; difficulty swallowing; tongue swelling; This is a spontaneous report from a contactable consumer. This consumer (parent) reported for a 16-Year-old non pregnant female patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EW0179), dose 1 via an unspecified route of administration, administered in Arm Right on 28Apr2021 18:45 as DOSE 1, SINGLE for covid-19 immunisation (Age at vaccination 16 years). Medical history and concomitant medications were not reported. No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. No covid tested post vaccination. No known allergies. No other medical history. On 28Apr2021 19:00 (within 10 min of vaccination) patient experienced feeling of throat closure, difficulty swallowing, tongue swelling. Therapeutic measures were taken as a result of feeling of throat closure (throat tightness), difficulty swallowing (dysphagia), tongue swelling (swollen tongue). Feeling of throat closure and difficulty swallowing beginning <10 minutes after receiving the vaccine. She was evaluated by medical personnel at the vaccination side and the symptoms seemed to resolve without treatment within 30 minutes (Benadryl was offered but declined at that time). However, after returning home a short time later, she experienced tongue swelling, feeling of throat closure, and difficulty swallowing. She took 50 mg of Benadryl. Symptoms continued in a remitting/recurring pattern for the next 2 hours. Did not seek emergency treatment because she did not have difficulty breathing. Approximately 2.5 hours after receiving the vaccine, symptoms were definitely lessening, and she went to sleep. The next morning on awakening she had mild residual tongue swelling, which completely resolved by mid-morning. The outcome for all events was recovered in an unspecified date in Apr2021.  No follow-up attempts are needed. No further information is expected.
heavy menstrual bleeding; This spontaneous case was reported by a nurse and describes the occurrence of HEAVY MENSTRUAL BLEEDING (heavy menstrual bleeding) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (heavy menstrual bleeding). At the time of the report, HEAVY MENSTRUAL BLEEDING (heavy menstrual bleeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details was not reported.  Treatment details was not provided by the reporter. This case concerns  a female with unknown age, with no reported medical history , who experienced Non-serious , unexpected event of Heavy menstrual bleeding which occurred on an unknown date, with an unknown dose number of mRNA-1273 vaccine ( Moderna Covid 19 vaccine ) . The re-challenge for this case is not applicable since the outcome of the event  is unknown and the details of the doses are also unknown. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine is not affected by this report; Sender's Comments: This case concerns  a female with unknown age, with no reported medical history , who experienced Non-serious , unexpected event of Heavy menstrual bleeding which occurred on an unknown date, with an unknown dose number of mRNA-1273 vaccine ( Moderna Covid 19 vaccine ) . The re-challenge for this case is not applicable since the outcome of the event  is unknown and the details of the doses are also unknown. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine is not affected by this report
Severe stomach pain with constipation.  After being checked by Dr., he prescribed baby fleet for the constipation.  After administering the fleet, he immediately had a bowel movement.  He had previously had a diarrhea type bowel movement approximately 1 hr prior to getting the dosage.
Pt received DMM around 1230p.  Pt's grandmother called our office at 230 stating pt was scream since 1 PM.  Advised to return with pt.  Grandmother called at 240 stating pt stopped screaming.
Severe pain in left arm from Tetanus shot at injection site, I was hot and cold and I had pain shooting down my left arm. Woke up to a pain above my collar bone to find a lump just above it. I went to my express care and the doctor informed me my lymph nodes were swollen. I set a appointment with my doctor, found two more tiny lumps before my appointment, and doctor took my blood work, which came back fine. She prescribed antibiotics (doxycycline) and said it was a reaction to the shot. I'm currently taking the medicine. I have a follow up in a month.
Breakthrough case admission after three doses Moderna 2/25/21 Lot# 025A21A Moderna 3/25/21 Lot# 028A21A Moderna 11/3/21 Lot# 933903
Felt like I was going to have heart attack. Could feel and  hear my heart. Major chilles, bones ache, nausea, sore throat, headache, sore arm, dizzy,  tired, confusion, depressed due to feeling so. As I?m guessing. this lasted 9 hours and then still had chills, headache, sick feeling and tired, runny nose, etc. hoping day 3 will feel better. Would never get it again. I thought I was goi g to die if a heart attack after second mixer a shot.
After injection it was swollen; After injection it was swollen and hurt, tender the second day; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE SWELLING (After injection it was swollen) and VACCINATION SITE PAIN (After injection it was swollen and hurt, tender the second day) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Fat redistribution: Sculptra (Had sculptra 6 years ago for fat loss). Concurrent medical conditions included HIV disease, Neuropathy, Sulfonamide allergy (Sulfa allergy) and Blood pressure management (Blood pressure issues NOS). Concomitant products included POLY-L-LACTIC ACID (SCULPTRA) for an unknown indication.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (After injection it was swollen) and VACCINATION SITE PAIN (After injection it was swollen and hurt, tender the second day). At the time of the report, VACCINATION SITE SWELLING (After injection it was swollen) and VACCINATION SITE PAIN (After injection it was swollen and hurt, tender the second day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications also included HIV medication, blood pressure medication, antioxidant face cream and supplements NOS. No treatment medication was provided.
Initial report received on 18 August 2010 from a health care professional. A 19-year-old male patient had received a first intramuscular left arm injection of MENACTRA (lot number U3510AA) on 16 August 2010. A one inch 25 gauge needle was used for the injection. That evening after receiving the vaccination the patient developed a temperature of 100.5 degrees Fahrenheit and complained of site soreness, redness, congestion, sore throat, and muscle aches. The patient received medical evaluation two days later on 18 August 2010 with continued complaint of sore throat and congestion. Rapid strep test was negative that day, and WBCs were 18.4. The patient was started on antibiotic therapy (trade name not reported). The patient was noted to have a "tickly throat" at the time of vaccination; and medical history included seasonal allergies. At the time of this report, the patient had not recovered. Follow-up information was received on 20 September 2010 from a health care professional. The patient's congestion was reported to be upper respiratory. He was treated with OMNICEF 300 mg one tablet twice a day for ten days (previously reported as "antibiotic"). The patient did not have any additional follow-up with the physician. No further information was provided at the time of this report. The patient's outcome was reported as recovered (date unknown by reporter). Documents held by sender: None.
Left arm redness & swelling. Treated with KEFLEX and follow up in 5 days. A: Cellulitis. P - KEFLEX & ER warnings.
Hep B, Prevnar 13, and Pentacel were given in error.  There was 3 children in the exam room and all of them were receiving vaccines.  The nurse grab the sib basket and administered them to patient in error.
Once I received vaccine, I felt a little tension on my left arm. I waited the 15 minutes and did not have a reaction.  The next day, I felt a little more tension in my arm; however I was able to move it and raise my arms at a normal level without resistance. The following day I felt no symptoms.
Sick for a few days; headache; Fever; Sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Sep-2021 and was forwarded to Moderna on 29-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for a few days), HEADACHE (headache), PYREXIA (Fever) and MYALGIA (Sore arm) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick for a few days), HEADACHE (headache), PYREXIA (Fever) and MYALGIA (Sore arm). At the time of the report, ILLNESS (Sick for a few days), HEADACHE (headache), PYREXIA (Fever) and MYALGIA (Sore arm) outcome was unknown.            Patient never had COVID-19.  No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Patient experienced extreme anxiety, believed she couldn't breathe. Had a high heart rate and pulse. Went with emt to be checked.
Left arm pain persisted for weeks after vaccine. When I returned for second dose on 1/8/21, I requested it be administered in my right arm, because left arm was still painful.  Two weeks after second dose, I returned to a local gym and begin working out with a trainer. It was apparent that my left arm had decreased ROM at the shoulder. The pain and ROM issues progressed over the next few months and became severe in May. I was  finally able to be seen by orthopedic surgeon who diagnosed frozen shoulder on July 7, 2021.
no adverse event; GARDASIL 9 was administered to a patient after expiry; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 03-NOV-2020, the patient was vaccinated with an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # N032284 (expiration date on 22-SEP-2020) (dosage, route of administration and anatomical route of administration were unknown) for prophylaxis. It was confirmed that the involved vaccine had not undergone any temperature excursions. At the reporting time, no adverse events were mentioned.
Narcolepsy with Cataplexy; cannot work and is on disability; Narcolepsy with Cataplexy; weakness in her legs; loses bodily control and drops to the floor with her eyes rolled back into her head; loses bodily control and drops to the floor with her eyes rolled back into her head; had changes in her body after receiving the vaccine; Initial information received on 13-Jan-2022 regarding an unsolicited valid serious case received from a consumer/non-hcp.  This case involves female patient of unknown age who had narcolepsy with cataplexy, cannot work and is on disability, narcolepsy with cataplexy, weakness in her legs, loses bodily control and drops to the floor with her eyes rolled back into her head, loses bodily control and drops to the floor with her eyes rolled back into her head and had changes in her body after receiving the vaccine while receiving vaccine INFLUENZA VACCINE (QUADRIVALENT).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 30-Nov-2010, the patient received an unknown dose of suspect INFLUENZA VACCINE (QUADRIVALENT) produced by unknown manufacturer (strength, formulation, frequency, route, administration site was unknown, lot UH214AB and expiry date was unknown) for prophylactic vaccination.  It was reported by patient that adverse reactions that have existed for 11 years that her world-renowned sleep physician, states it stems from that vaccine. Patient stated that she had changes in her body after receiving the vaccine (unevaluable event), she had experienced weakness in her legs (Muscular weakness) and had been diagnosed with Narcolepsy with Cataplexy (Narcolepsy, cataplexy) (onset and latency: unknown). Reportedly stated that she loses bodily control (Balance disorder) and drops to the floor with her eyes rolled back into her head (eye movement disorder) (onset and latency: unknown). Patient had a letter from her doctor describing the events, she states she cannot work and was on disability (impaired work ability) (onset and latency: unknown). Patient wonders what the company would do to compensate her for her struggles  Action taken: not applicable.  Corrective treatment: not reported  Outcome: unknown for unevaluable event and not recovered for other events  Seriousness criteria: Medically significant for event narcolepsy, cataplexy and disability for impaired work ability; Sender's Comments: Sanofi company comment dated 13-Jan-2022: This case involves female patient of unknown age who had Narcolepsy, Impaired work ability and Cataplexy after receiving INFLUENZA VACCINE (QUADRIVALENT). (Manufacturer unknown). The time to onset is not reported with the role of the vaccine. The clinical course of the event was not provided. Furthermore, information regarding condition at the time of vaccination, role of medical history, concomitants, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of an individual vaccine cannot be assessed.
Allergies; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 27-year-old female patient (unknown if pregnant) received BNT162b2 (BNT162B2), on 07Dec2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 27 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Prev dose product: COVID 19,, Prev dose brand: Pfizer,, Prev dose lot number: EL3247,, Prev dose dose number: 1), administration date: 01Feb2021, when the patient was 26-year-old, for COVID-19 Immunization, reaction(s): "PCR Positive", "Cough", "Congestion"; BNT162b2 (Prev dose product: COVID 19,, Prev dose brand: Pfizer,, Prev dose lot number: EL3247,, Prev dose dose number: 2), administration date: 22Feb2021, when the patient was 26-year-old, for COVID-19 Immunization, reaction(s): "PCR Positive", "Cough", "Congestion". The following information was reported: HYPERSENSITIVITY (non-serious) with onset Apr2022, outcome "unknown", described as "Allergies". It was unknown if therapeutic measures were taken as a result of hypersensitivity.  No follow-up attempts are possible. No further information is expected.